atalanta - Search News

Atalanta, Gian Piero Gasperini

Soccer-Barca's Balde clueless about Atalanta's Gasperini

Barcelona defender Alejandro Balde may have unwittingly handed his side's Champions League opponents Atalanta some extra motivation when he admitted that he had never heard of their manager. Balde was full of praise for Atalanta,

Yahoo! Sports · 7h

Gasperini: ‘Only a win’ is enough for Atalanta, but Barcelona ‘test’ more important

Gian Piero Gasperini is aware of the fact that Atalanta require a win away against Barcelona to guarantee themselves a spot in the top eight of the Champions League standings, but insists that he is

Stats Perform (Video) on MSN · 8h

Gasperini has done 'unbelievable' job with Atalanta - Flick

Barcelona boss Hansi Flick has high praise for the work Gian Piero Gasperini has done with 'unique' Atalanta Michigan Democratic Sen. Gary Peters will not run for reelection, opening a key Senate seat in 2026 Why meteorologists are comparing Storm Éowyn to a bomb If you and your partner use any of these 5 phrases regularly,

Atalanta, Barcelona and Champions League

CBSSports.com on MSN · 16h

Barcelona vs. Atalanta: Where to watch UEFA Champions League live stream online, TV channel, prediction, odds

Barcelona and Atalanta meet in Catalonia on Wednesday for their final UEFA Champions League game of the league phase. Hansi Flick's men are already guaranteed a top eight finish, but could yet finish top while Gian Piero Gasperini's side are attempting to confirm a round of 16 place alongside the Blaugrana at Estadi Olimpic Lluis Companys.

Talksport · 1h

Barcelona vs Atalanta predictions, odds and betting tips

Barcelona and Atalanta conclude the league phase of the Champions League against one another. Barcelona vs Atalanta best bets Atalanta or draw – 11/10 with Sky Bet Over 3.5 goals –

The Associated Press – Sports o… · 6h

Barcelona sticks with Szczesny in goal for Champions League match against Atalanta

Hansi Flick is keeping Wojciech Szczesny in goal for the final match of the league phase of the Champions League on Wednesday.

Lookman to miss Atalanta vs. Barcelona with injury

BBC · 9h

Lookman ba zai buga wa Atalanta wasa da Barcelona ba

Ademola Lookman ba zai buga wa Atalanta Champions League da za ta kara da Barcelona ba, kamar yadda ƙungiyar da ke buga Serie A ta sanar ranar Talata.

Yahoo! Sports · 14h

Lookman injury: Atalanta star ruled out of Barcelona clash

Ademola Lookman has a knee problem and will not be available for Wednesday’s Champions League match against Barcelona, reports La Gazzetta dello Sport.Nigeria international Lookman will miss

Daily Post Nigeria on MSN · 13h

UCL: Lookman to miss Atalanta vs Barcelona with injury

Ademola Lookman has been ruled out of Atalanta’s UEFA Champions League clash with Barcelona. Lookman sustained a knee injury in Atalanta’s Serie A clash against Como last weekend. The Nigeria international is expected to be sidelined for a number of weeks.

4hon MSN

Atalanta set sights on top-eight finish ahead of final game against Barcelona

Atalanta have outperformed their expectations in the Champions League this season and will now make one final push in their ...

FC Barcelona1h

PREVIEW | FC Barcelona v Atalanta

Meanwhile, Atalanta are without Ivorian loanee from Leverkusen Odilon Kossounou in defence and Italian international striker ...

BioPharma Dive12h

Atalanta banks $97M to send RNAi drugs into the brain

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.

BioSpace10h

Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...

14h

Boston biotech Atalanta raises $97M to bring CNS drugs into clinic

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.